SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: THE ANT who wrote (178610)9/19/2021 5:55:02 PM
From: carranza2  Read Replies (2) | Respond to of 217917
 
Killing more of the young than the virus?

Respectfully, that is definitely not at all how I read the data.



To: THE ANT who wrote (178610)9/19/2021 6:19:32 PM
From: jazzlover2  Respond to of 217917
 



To: THE ANT who wrote (178610)9/20/2021 11:10:00 AM
From: arun gera  Read Replies (2) | Respond to of 217917
 
<They hid the benefits of ivermectin this changes the equation.>

Why are you still obsessed with Ivermectin? I would be more concerned with the downplaying of weakened virus Sinovac, which is being used by a billion chinese and a lot of other countries including Brazil.

-Arun



To: THE ANT who wrote (178610)9/20/2021 11:12:14 AM
From: arun gera  Read Replies (2) | Respond to of 217917
 
<The vaccine risk benefit makes it appropriate for certain populations but it’s killing more of the young than the illness itself would>

I don't think we have had enough time to even generate enough data on that to make a meaningful determination.

-Arun


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News